|
Welcome and Opening Remarks
Tania Sorrell
|
|
Epidemiology of serious fungal infections in the Asia Pacific region
David Ellis, Women's & Children's Hospital
|
|
New antifungal agents: meeting the unmet needs in serious fungal infections.
John Edwards
|
|
Changing the face of aspergillosis therapy: Results of a recent clinical trial
Changing the face of aspergillosis therapy: Results of a recent clinical trial, pharmacokinetic and safety considerations
Ben de Pauw
|
|
Selecting an appropriate early treatment strategy
Kieren Marr
|
|
Closing Remarks
John Edwards
|